These observations indicate that let-7g emerges as a significant target in NPC tumors due to the regulation of KRAS expression and its downstream PI3K−Rac1−Akt−BCL-2/BCL-xL-mediated bioenergetic and apoptotic signaling pathways. The gene discussed is BCL2L1; the disease is nasopharyngeal carcinoma.